［1］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］.CA Cancer J Clin,2021,71(3):209-249.
［2］TOKUNAGA M,SATO Y,NAKAGAWA M,et al.Perioperative chemotherapy for locally advanced gastric cancer in Japan:current and future perspectives ［J］.Surg Today,2020,50(1):30-37.
［3］BONNAY F,VELOSO A,STEINMANN V,et al.Oxidative metabolism drives immortalization of neural stem cells during tumorigenesis ［J］.Cell,2020,182(6):1490-1507 e1419.
［4］GAUDE E,FREZZA C.Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival ［J］.Nat Commun,2016:7:13041.
［5］WALSH HR,CRUICKSHANK BM,BROWN JM,et al.The flick of a switch:conferring survival advantage to breast cancer stem cells through metabolic plasticity ［J］.Front Oncol,2019,9:753.
［6］LUNT SY,VANDER HEIDEN MG.Aerobic glycolysis:meeting the metabolic requirements of cell proliferation ［J］.Annu Rev Cell Dev Biol,2011,27:441-464.
［7］WARBURG O,WIND F,NEGELEIN E.The metabolism of tumors in the body ［J］.J Gen Physiol,1927,8(6):519-530.
［8］HANAHAN D,WEINBERG RA.Hallmarks of cancer:the next generation ［J］.Cell,2011,144(5):646-674.
［9］VAUPEL P,SCHMIDBERGER H,MAYER A.The Warburg effect:essential part of metabolic reprogramming and central contributor to cancer progression ［J］.Int J Radiat Biol,2019,95(7):912-919.
［10］LIN DC,HAO JJ,NAGATA Y,et al.Genomic and molecular characterization of esophageal squamous cell carcinoma ［J］.Nat Genet,2014,46(5):467-473.
［11］LAMBERT AW,PATTABIRAMAN DR,WEINBERG RA.Emerging biological principles of metastasis ［J］.Cell,2017,168(4):670-691.
［12］CLEVERS H.The intestinal crypt,a prototype stem cell compartment ［J］.Cell,2013,154(2):274-284.
［13］MACCALLI C,RASUL KI,ELAWAD M,et al.The role of cancer stem cells in the modulation of anti-tumor immune responses ［J］.Semin Cancer Biol,2018,53:189-200.
［14］YANG J,REN B,YANG G,et al.The enhancement of glycolysis regulates pancreatic cancer metastasis ［J］.Cell Mol Life Sci,2020,77(2):305-321.
［15］FU QF,LIU Y,FAN Y,et al.Alpha-enolase promotes cell glycolysis,growth,migration,and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway ［J］.J Hematol Oncol,2015,8:22.
［16］SUN L,LU T,TIAN K,et al.Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway ［J］.Eur J Pharmacol,2019,845:8-15.
［17］GATENBY RA,GILLIES RJ.Why do cancers have high aerobic glycolysis［J］.Nat Rev Cancer,2004,4(11):891-899.
［18］BHATIA S,P WANG,A TOH,et al.New insights into the role of phenotypic plasticity and EMT in driving cancer progression ［J］.Front Mol Biosci,2020,7:71.
［19］FENDT SM,FREZZA C,EREZ A.Targeting metabolic plasticity and flexibility dynamics for cancer therapy ［J］.Cancer Discov,2020,10(12):1797-1807.
［20］MCDONALD OG,LI X,SAUNDERS T,et al.Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis ［J］.Nat Genet,2017,49(3):367-376.
［21］CHANO T,AVNET S,KUSUZAKI K,et al.Tumour-specific metabolic adaptation to acidosis is coupled to epigenetic stability in osteosarcoma cells ［J］.Am J Cancer Res,2016,6(4):859-875.
［22］FLAVAHAN WA,DRIER Y,LIAU BB,et al.Insulator dysfunction and oncogene activation in IDH mutant gliomas ［J］.Nature,2016,529(7584):110-114.
［23］SCIACOVELLI M,GONCALVES E,JOHNSON TI,et al.Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition ［J］.Nature,2016,537(7621):544-547.
［24］WU D,HU D,CHEN H,et al.Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer ［J］.Nature,2018,559(7715):637-641.
［25］RAFFEL S,FALCONE M,KNEISEL N,et al.BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation ［J］.Nature,2017,551(7680):384-388.
［26］STEMMLER MP,ECCLES RL,BRABLETZ S,et al.Non-redundant functions of EMT transcription factors ［J］.Nat Cell Biol,2019,21(1):102-112.
［27］PRASAD CP,GOGIA A,BATRA A.Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis ［J］.Clin Transl Oncol,2022,24(10):1844-1855.
［28］YANG L,YAN X,CHEN J,et al.Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients ［J］.Proc Natl Acad Sci USA,2021,118(11):1-11.
［29］LI HJ,KE FY,LIN CC,et al.ENO1 promotes lung cancer metastasis via HGFR and WNT signaling-driven epithelial-to-mesenchymal transition ［J］.Cancer Res,2021,81(15):4094-4109.
［30］XIAO H,ZHANG L,CHEN Y,et al.PKM2 promotes breast cancer progression by regulating epithelial mesenchymal transition ［J］.Anal Cell Pathol (Amst),2020,2020:8396023.
［31］ZHANG Y,LIN S,CHEN Y,et al.LDH-A promotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer ［J］.Onco Targets Ther,2018,11:2363-2373.
［32］HOU X,SHI X,ZHANG W,et al.LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma ［J］.Cell Death Dis,2021,12(4):347.
［33］DAS CK,PAREKH A,PARIDA PK,et al.Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer ［J］.Biochim Biophys Acta Mol Cell Res,2019,1866(6):1004-1018.
［34］ZHAO H,DUAN Q,ZHANG Z,et al.Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells ［J］.J Cell Mol Med,2017,21(9):2055-2067.
［35］AZOITEI N,BECHER A,STEINESTEL K,et al.PKM2 promotes tumor angiogenesis by regulating HIF-1alpha through NF-kappaB activation ［J］.Mol Cancer,2016,15:3.
［36］ZHANG W,ZHANG X,HUANG S,et al.FOXM1D potentiates PKM2-mediated tumor glycolysis and angiogenesis ［J］.Mol Oncol,2021,15(5):1466-1485.
［37］YANG W,XIA Y,JI H,et al.Corrigendum:Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation ［J］.Nature,2017,550(7674):142.
［38］LI L,ZHANG Y,QIAO J,et al.Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis ［J］.J Biol Chem,2014,289(37):25812-25821.
［39］LI Z,YANG P,LI Z.The multifaceted regulation and functions of PKM2 in tumor progression ［J］.Biochim Biophys Acta,2014,1846(2):285-296.
［40］DE BOCK K,GEORGIADOU M,SCHOORS S,et al.Role of PFKFB3-driven glycolysis in vessel sprouting ［J］.Cell,2013,154(3):651-663.
［41］HUINEN ZR,HUIJBERS EJM,VAN BEIJNUM JR,et al.Anti-angiogenic agents-overcoming tumour endothelial cell anergy and improving immunotherapy outcomes ［J］.Nat Rev Clin Oncol,2021,18(8):527-540.
［42］XU Z,GUO C,YE Q,et al.Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization ［J］.Nat Commun,2021,12(1):6310.
［43］PAYEN VL,MINA E,VAN HEE VF,et al.Monocarboxylate transporters in cancer ［J］.Mol Metab,2020,33:48-66.
［44］WANG ZH,PENG WB,ZHANG P,et al.Lactate in the tumour microenvironment:From immune modulation to therapy ［J］.EBioMedicine,2021,73:103627.
［45］IPPOLITO L,MORANDI A,GIANNONI E,et al.Lactate:a metabolic driver in the tumour landscape ［J］.Trends Biochem Sci,2019,44(2):153-166.
［46］WATSON MJ,VIGNALI PDA,MULLETT SJ,et al.Metabolic support of tumour-infiltrating regulatory T cells by lactic acid ［J］.Nature,2021,591(7851):645-651.
［47］XIA H,WANG W,CRESPO J,et al.Suppression of FIP200 and autophagy by tumor-derived lactate promotes naive T cell apoptosis and affects tumor immunity ［J］.Sci Immunol,2017,2(17):1-29.
［48］BRAND A,SINGER K,KOEHL GE,et al.LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells ［J］.Cell Metab,2016,24(5):657-671.
［49］COLEGIO OR,CHU NQ,SZABO AL,et al.Functional polarization of tumour-associated macrophages by tumour-derived lactic acid ［J］.Nature,2014,513(7519):559-563.
［50］DOHERTY JR,CLEVELAND JL.Targeting lactate metabolism for cancer therapeutics ［J］.J Clin Invest,2013,123(9):3685-3692.
［51］HIRSCHHAEUSER F,SATTLER UG,MUELLER-KLIESER W.Lactate:a metabolic key player in cancer ［J］.Cancer Res,2011,71(22):6921-6925.
［52］NIU D,LUO T,WANG H,et al.Lactic acid in tumor invasion ［J］.Clin Chim Acta,2021,522:61-69.
［53］KUNHIRAMAN H,EDATT L,THEKKEVEEDU S,et al.2-deoxy glucose modulates expression and biological activity of VEGF in a SIRT-1 dependent mechanism ［J］.J Cell Biochem,2017,118(2):252-262.
［54］JANG M,KIM SS,LEE J.Cancer cell metabolism:implications for therapeutic targets ［J］.Exp Mol Med,2013,45:e45.
［55］MALM SW,HANKE NT,GILL A,et al.The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines ［J］.J Exp Clin Cancer Res,2015,34:31.
［56］RAEZ LE,PAPADOPOULOS K,RICART AD,et al.A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors ［J］.Cancer Chemother Pharmacol,2013,71(2):523-530.
［57］GAO S,SONG D,LIU Y,et al.Helicobacter pylori CagA protein attenuates 5-Fu sensitivity of gastric cancer cells through upregulating cellular glucose metabolism ［J］.Onco Targets Ther,2020,13:6339-6349.
［58］YAKISICH JS,AZAD N,KAUSHIK V,et al.The biguanides metformin and buformin in combination with 2-deoxy-glucose or WZB-117 inhibit the viability of highly resistant human lung cancer cells ［J］.Stem Cells Int,2019,2019:6254269.